Optimi Health (OPTI) AI Stock Analysis

• Market Cap: C$16.43M
• Dividend Yield: N/A
• Average Volume (3M): 53.16K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.12
• Revenue Growth: 89.28%
• EPS Growth: 18.45%
• Country: CA
• Employees: 9
• Sector: Healthcare
• Sector Strength: 41
• Industry: Agricultural Farm Products
• EPS (TTM): >-0.01
• Shares Outstanding: 96,638,170
• 10 Day Avg. Volume: 48,470
• 30 Day Avg. Volume: 53,160
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 48 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

Optimi Health's overall stock score is primarily influenced by its financial performance, which shows potential but is overshadowed by significant risks due to persistent losses and cash flow challenges. Technical analysis provides some positive signals, but valuation remains a concern with a negative P/E ratio.

Optimi Health Business Overview & Revenue Model

Company Description

Optimi Health (OPTI) is a health and wellness company focused on providing innovative solutions in the realm of mental health and well-being. Operating primarily within the digital health sector, Optimi Health offers a range of products and services, including telehealth consultations, online therapy platforms, and digital wellness programs designed to improve mental health and overall quality of life. The company aims to leverage technology to make mental health support more accessible and effective for individuals and organizations.

How the Company Makes Money

Optimi Health generates revenue through multiple channels including subscription fees for its telehealth and online therapy services, which provide users with access to licensed mental health professionals. Additionally, the company may earn income from partnerships with employers and organizations that integrate its wellness programs into their employee health initiatives. The revenue model is further supported by potential licensing agreements for its proprietary digital health technologies and platforms. Strategic collaborations with healthcare providers and insurers can also contribute to revenue growth by expanding the reach of its services and enhancing its offerings.

Optimi Health Financial Statement Overview

Summary

Optimi Health exhibits revenue growth and sturdy equity levels, indicating potential for future profitability. However, persistent losses, negative cash flows, and reliance on external funding pose considerable financial risks. The company must focus on improving operational efficiency and cash management to enhance financial health.

Income Statement

Optimi Health's revenue has shown growth from $0 in 2020 to $389,850 in 2024, indicating an upward trend. However, the company has consistently reported negative net income, with a significant net loss of $6,035,859 in 2024. The gross profit margin for 2024 is relatively healthy at 69.5%, but the absence of EBIT and negative EBITDA highlight challenges in operational efficiency.

Balance Sheet

The company maintains a high equity ratio, with stockholders’ equity consistently exceeding total liabilities, indicating financial stability. The debt-to-equity ratio is moderate at 0.29 in 2024, suggesting manageable leverage. However, the declining trend in total assets and stockholders' equity since 2021 should be monitored.

Cash Flow

Optimi Health's cash flow demonstrates a challenging picture with negative operating and free cash flows in all observed years, reflecting cash management issues. The operating cash flow to net income ratio is negative, underscoring cash flow inadequacy to cover net losses. Despite positive financing cash flows, reliance on external financing is evident.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	389.85K	181.09K	80.72K	0.00	0.00
Gross Profit	270.91K	-157.04K	53.92K	-47.12K	-5.42K
EBITDA	-4.74M	-4.42M	-7.03M	-5.95M	-161.14K
Net Income	-6.04M	-5.19M	-7.38M	-6.04M	-169.22K
Balance Sheet
Total Assets	14.55M	16.49M	16.82M	23.46M	6.17M
Cash, Cash Equivalents and Short-Term Investments	103.66K	1.34M	1.89M	12.43M	4.47M
Total Debt	2.75M	1.71M	157.58K	250.84K	156.32K
Total Liabilities	4.98M	3.28M	797.66K	2.40M	882.66K
Stockholders Equity	9.58M	13.21M	16.02M	21.07M	5.29M
Cash Flow
Free Cash Flow	-4.43M	-4.41M	-11.73M	-10.96M	-898.27K
Operating Cash Flow	-4.28M	-3.60M	-4.58M	-6.02M	-143.45K
Investing Cash Flow	-154.02K	-706.02K	-3.15M	-9.19M	-754.83K
Financing Cash Flow	3.19M	3.76M	1.19M	19.18M	5.37M

Optimi Health Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.16
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OPTI, the sentiment is Negative. The current price of 0.16 is above the 20-day moving average (MA) of 0.16, above the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 49.70 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:OPTI.

Optimi Health Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	¥341.94B	11.51	-0.17%	2.40%	9.60%	-10.22%
ROMJ	64 Neutral	$39.63M	―	-2.68%	―	29.78%	68.83%
NLH	61 Neutral	C$26.19M	176.32	0.69%	―	11.89%	5.56%
CWEB	56 Neutral	$26.26M	―	-85.33%	―	-5.03%	50.71%
OPTI	48 Neutral	C$16.43M	―	-48.35%	―	89.28%	18.45%
PHRM	44 Neutral	C$39.83M	―	-76.00%	―	―	66.13%

Optimi Health Corporate Events

Optimi Health Secures $3.45 Million Financing and Extends Loan

Optimi Health Corp. has announced a $3.45 million convertible financing through a non-brokered private placement with two investors, which includes the company’s CEO and Chair of the Board. The funds will be used for general working capital, and the offering is expected to close by July 24, 2025. Additionally, Optimi has extended its secured term loan of $1 million, with a new maturity date set for April 30, 2026. This extension includes the issuance of 400,000 common share purchase warrants as partial consideration for the loan extension.